lyophilisation comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
Lyophilized peptide powder is normally held desiccated at −20 °C, with −80 °C used for longer storage periods. Allowing a sealed vial to reach room temperature before opening is standard practice, because condensation forming on cold powder introduces moisture. Once dissolved, solutions are typically kept cold and shielded from light. Repeated freeze-thaw cycles are avoided because they encourage aggregation and gradual loss of material. These conventions are general to synthetic peptides rather than unique to any one sequence.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
| Property | Value | Notes |
|---|---|---|
| Dosage form | Lyophilized powder in sealed vial | Reconstituted before analytical or laboratory use |
| Reconstitution solvent | Sterile or bacteriostatic water | Bacteriostatic water limits microbial growth in multi-use vials |
| Typical working pH | Near neutral, buffered | Strongly acidic or basic conditions promote degradation |
| Stability indicator | Loss of main HPLC peak over time | Aggregation and oxidation are common degradation routes |
| Documentation | Batch certificate of analysis | Covers identity, purity and sometimes sterility testing |
Identity and purity are assessed with a small set of standard techniques. Reverse-phase high-performance liquid chromatography gives a purity estimate from peak area, usually recorded at 214 or 220 nanometers, where the peptide bond absorbs. Mass spectrometry confirms the expected molecular mass and can reveal truncated or oxidized species. Amino acid analysis or tandem mass spectrometry sequencing can verify the sequence itself. Additional quality attributes include water content, residual trifluoroacetic acid carried over from purification, and endotoxin where the material is intended for biological work.
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
=== Brand names === Buserelin is marketed by Sanofi-Aventis primarily under the brand names Suprefact, Suprefact Depot, and Suprecur. It is also available under a number of other brand names including Bigonist, Bucel, Buserecur, Fuset, Metrelef, Profact, Profact Depot, Supremon, and Zerelin. CinnaFact is a generic version of the medication that is produced by CinnaGen. Buserelin is marketed for use in veterinary medicine primarily under the brand name Receptal, but is also available under the brand names Buserol, Busol, Porceptal, and Veterelin.
== Critical reception == Gordon Freeman quickly became and then remained one of the most popular video game characters ever. In 2008, The Age ranked him as the 16th-best Xbox character of all time, adding that "no one has done more for the reputations and street cred of theoretical physicists than Valve." In 2009, GameDaily listed the "strong and silent type" in their top 25 video game archetypes, using Gordon Freeman as an example. In 2010, Empire ranked him as the number one Greatest Video Game Character, commenting that "the character is the quintessential geek fantasy" who "has become a gaming icon, synonymous with the apotheosis of first-person action." He was also ranked 14th on UGO.com's list of top 100 heroes in all media, with a comment that "an MIT graduate, donning black-framed glasses and a goatee, he's not the guy you'd picture decimating the alien threat." In 2012, GamesRadar ranked him as the sixth "most memorable, influential, and badass" protagonist in games, adding: "It's how the characters of the Half-Life universe treat Gordon Freeman, not the way he treats them, that shape such a compelling character." In 2013, Complex ranked him as the 45th "most badass" video game character of all time. In 1998, readers of GameSpot ranked him as the fifth-best Hero of gaming. In 2009, a public poll on GameSpot resulted in him being voted the All Time Greatest Video Game Hero. He was also voted as the eighth-best video game character of all time in the Guinness World Records Gamer's Edition 2011.
== Perspectives == Synthetic biology is a field whose scope is expanding in terms of systems integration, engineered organisms, and practical findings. Engineers view biology as technology (in other words, a given system includes biotechnology or its biological engineering). Synthetic biology includes the broad redefinition and expansion of biotechnology, with the ultimate goal of being able to design and build engineered live biological systems that process information, manipulate chemicals, fabricate materials and structures, produce energy, provide food, and maintain and enhance human health, as well as advance fundamental knowledge of biological systems (see Biomedical engineering) and our environment. Researchers and companies working in synthetic biology are using nature's power to solve issues in agriculture, manufacturing, and medicine. Due to more powerful genetic engineering capabilities and decreased DNA synthesis and sequencing costs, the field of synthetic biology is rapidly growing. In 2016, more than 350 companies across 40 countries were actively engaged in synthetic biology applications; all these companies had an estimated net worth of $3.9 billion in the global market. Synthetic biology currently has no generally accepted definition. Here are a few examples: It is the science of genetic and physical engineering to produce new (and, therefore, synthetic) life forms.
== External links == Sean R. Eddy (2004). "Where did the BLOSUM62 alignment score matrix come from?". Nature Biotechnology. 22 (8): 1035–6. doi:10.1038/nbt0804-1035. PMID 15286655. S2CID 205269887. BLOCKS WWW server Scoring systems for BLAST at NCBI Data files of matrices including BLOSUM30–100 on the NCBI FTP server. Interactive BLOSUM Network Visualization Archived 30 January 2017 at the Wayback Machine
Sources: en.wikipedia.org
Alkylglycerone phosphate synthase (EC 2.5.1.26, alkyldihydroxyacetonephosphate synthase, alkyldihydroxyacetone phosphate synthetase, alkyl DHAP synthetase, alkyl-DHAP, dihydroxyacetone-phosphate acyltransferase, DHAP-AT) is an enzyme associated with Type 3 Rhizomelic chondrodysplasia punctata. This enzyme catalyses the following chemical reaction
The Canadian Penning Trap Mass Spectrometer (CPT) is one of the major pieces of experimental equipment that is installed on the ATLAS superconducting heavy-ion linac facility at the Physics Division of the Argonne National Laboratory. It was developed and operated by physicist Guy Savard and a collaboration of other scientists at Argonne, the University of Manitoba, McGill University, Texas A&M University and the State University of New York.
=== October === October 1 The US imposes new sanctions on Iran, targeting rail, automotive, manufacturing, and steel sectors, as well as overseas suppliers, saying that the goal is to economically isolate the Iranian government. The US military starts sending about 9,000 soldiers to the Middle East on naval ships, such as the USS Makin Island amphibious readiness group and the USS Theodore Roosevelt carrier strike group. October 2 The US imposes sanctions on Hamas' financing network, which includes two French-based funds. Alabama state representative Brett Easterbrook is arrested on charges of first-degree human trafficking and prostitution as part of a sting. At least a dozen other men are arrested. October 3 – Trump establishes a task force to examine the risks and opportunities of AI and recommend what role the federal government should play in overseeing the technology without compromising competitiveness with China. October 4 The State Department announces that the US "kicked out" two members of the Iranian delegation who attended the recent United Nations General Assembly after they ignored an order to leave the country long after the General Assembly had ended. Trump withdraws all US bombers from RAF Fairford, a British air base targeted by an attack that the UK linked to the Iranian government, due to urgent concerns about a potentially complex drone attack ordered by the IRGC as part of a plot to target the aircraft and kill American soldiers at RAF Fairford, which is loosely modeled after Ukraine's Operation Spiderweb.
=== Pharmacokinetics === Exposure to radioactive waste may cause health impacts due to ionizing radiation exposure. In humans, a dose of 1 sievert carries a 5.5% risk of developing cancer, and regulatory agencies assume the risk is linearly proportional to dose even for low doses. Ionizing radiation can cause deletions in chromosomes. If a developing organism such as a fetus is irradiated, it is possible a birth defect may be induced, but it is unlikely this defect will be in a gamete or a gamete-forming cell. The incidence of radiation-induced mutations in humans is small, as in most mammals, because of natural cellular-repair mechanisms, many just now coming to light. These mechanisms range from DNA, mRNA and protein repair, to internal lysosomic digestion of defective proteins, and even induced cell suicide—apoptosis Depending on the decay mode and the pharmacokinetics of an element (how the body processes it and how quickly), the threat due to exposure to a given activity of a radioisotope will differ. For instance, iodine-131 is a short-lived beta and gamma emitter, but because it concentrates in the thyroid gland, it is more able to cause injury than caesium-137 which, being water soluble, is rapidly excreted through urine. In a similar way, the alpha emitting actinides and radium are considered very harmful as they tend to have long biological half-lives and their radiation has a high relative biological effectiveness, making it far more damaging to tissues per amount of energy deposited.
λ indicates the radioactivity decay constant in nuclear physics and radioactivity. This constant is very simply related (by a multiplicative constant) to the half-life of any radioactive material. In evolutionary algorithms, λ indicates the number of offspring that would be generated from μ current population in each generation. The terms μ and λ are originated from evolution strategy notation.
Sources: en.wikipedia.org
Official website Official news & press Burger King McLamore Foundation. Archived June 12, 2018, at the Wayback Machine. Liz's Legacy Cancer Fund BK Beat Cancer for Kids Business data for Burger King: Burger King at the Wayback Machine (archived March 24, 2002) "Burger King". Archived from the original on April 19, 2001. Retrieved December 9, 2013. "Burger King". Archived from the original on October 12, 1997. Retrieved May 18, 2005. "Burger King". Archived from the original on December 26, 1996. Retrieved November 10, 2016.
==== Antidepressants ==== Antidepressants are one of the common drugs for fibromyalgia. Antidepressants can improve the quality of life for fibromyalgia patients in the medium term. Duloxetine and milnacipran have good evidence of substantial pain relief, with no increased risk for serious adverse effects. A 2023 meta-analysis found that duloxetine improved fibromyalgia symptoms, regardless of the dosage. SSRIs may be also be used to treat depression in people diagnosed with fibromyalgia. While amitriptyline has been used as a first-line treatment, the quality of evidence to support this use is poor. Very weak evidence indicates that a very small number of people may benefit from treatment with the tetracyclic antidepressant mirtazapine, however, for most, the potential benefits are not great and the risk of adverse effects and potential harm outweighs any potential for benefit. Tentative evidence suggests that monoamine oxidase inhibitors (MAOIs) such as pirlindole and moclobemide are moderately effective for reducing pain. Very low-quality evidence suggests pirlindole as more effective at treating pain than moclobemide. Side effects of MAOIs may include nausea and vomiting. For sleep quality, there is no good evidence showing that amitriptyline, milnacipran or duloxetine give improvement.
In addition, Gaboon vipers produce the most painful bite of any venomous snake in the world. A bite causes very rapid and conspicuous swelling, intense pain, severe shock and local blistering. Other symptoms may include uncoordinated movements, defecation, urination, swelling of the tongue and eyelids, convulsions and unconsciousness. Blistering, bruising and necrosis is often very extensive. There may be sudden hypotension, heart damage and dyspnoea. The blood may become incoagulable with internal bleeding that may lead to haematuria and haematemesis. Local tissue damage may require surgical excision and possibly amputation. Healing may be slow and fatalities during the recovery period are not uncommon.
The Great Zimbabwe Bird first appeared in an armorial sense when it was incorporated in the coat of arms of Southern Rhodesia, which were granted by Royal Warrant on 11 August 1924. It was first used on a national flag when the full arms were displayed on the Rhodesian flag that was adopted on 11 November 1968. It then appeared alone on the Zimbabwe Rhodesian flag of 1979, and it is now displayed on the flag of Zimbabwe. The arms of 1924 were initially retained by the Zimbabwean Government until a new coat of arms were adopted on 12 September 1981. The Zimbabwe Bird depicted on the flag is rendered in the same format as it appeared on the arms of 1924 and as it appeared on the Rhodesian flag of 1968 and the Zimbabwe Rhodesian flag of 1979. The red star on which the bird is placed is a regular star. However, a different, rather flattened version of the bird, sometimes displayed on an irregular, flattened star, is often seen on flags that are manufactured outside of Zimbabwe. The origin of this discrepancy appears to be an illustration of the proposed new flag that was first released by the Zimbabwe Ministry of Information in April 1980, just prior to the country attaining full independence. This illustration showed the bird in a flattened version positioned over an irregular star.
=== Eggs and hatchlings === C. brunneus lay eggs in a variety of habitats from chalk hills to sandy hills but most commonly lay their eggs in sandy, dry habitats. In the lab, C. brunneus prefer dry and compact substrates composed of fine particles such as sand. They produce the largest number of eggs between 28-35 °C degrees. In theory, smaller eggs should have higher mortality rates because of reduced provisions provided within the egg. However researchers found that egg viability is greater in the southern populations where eggs are smaller. This can be explained by higher overwintering temperatures. Egg size is influenced by a number of factors. As maternal age increases so does egg size. At the beginning of the breeding season females lay smaller eggs compared to the end of the breeding season. Eggs laid in the last part of the breeding season are smaller in size due to deteriorating maternal health. Research suggests that there is no correlation between stage of development and water uptake. While eggs can withstand a large amount of water loss they cannot survive complete desiccation. Therefore, it is not important at what point water is absorbed, it is only important that water is absorbed at some point. A larger egg size generally results in a larger hatchling and adult size. Eggs laid by C. brunneus from late August to early September are the heaviest, hatch the latest, and have heavier hatchlings. While earlier hatchlings are initially smaller, earlier hatchlings achieve a larger body size than later hatchlings.
Sources: en.wikipedia.org
Desiccated storage at −20 °C is conventional, with −80 °C for extended periods. Vials should be warmed to room temperature before opening to prevent condensation on the powder.
It usually reports batch-specific results for purity by chromatography, identity by mass spectrometry, and sometimes peptide content and residual solvents. It applies only to the batch tested, not to a supplier's wider stock.
Purity describes the proportion of the chromatographic signal from the target compound, while peptide content measures how much of the vial's physical mass is peptide. Counter-ions, water and residual acid make up the remainder, so content values are commonly lower.
The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.